KC Scotland
SMC approve of nivolumab and cabozantinib
Statement from Kidney Cancer Scotland on the news of the SMC’s approval of nivolumab and cabozantinib for late stage kidney cancer patients... Read More
Promising Combination Moves Into Kidney Cancer
Bavencio and Inlyta combined produced a promising response for some patients with kidney cancer (renal cell carcinoma). According to findings from the phase... Read More
Some gene mutations identified in ccRCC
Researchers from the University of Zurich have now identified some of the gene mutations that contribute to the development of carcinomas in... Read More
New genetic cause of Wilms tumour discovered
Scientists have identified a new genetic cause of a childhood kidney cancer called Wilms tumour – revealing insights into how loss of... Read More
Effective cancer treatments in the future
Scientists are optimistic that gene-editing techniques could lead the way toward new, more effective cancer treatments that are also less harmful to... Read More
World Kidney Cancer Q&A Day
June 22 will mark the first World Kidney Cancer Q&A Day – a day where the global kidney cancer community of patients,... Read More
Research Profiles Immune Landscape in Kidney Cancer
NEW YORK (GenomeWeb) – A team led by researchers at the University of Zurich has generated a profile of the immune cell... Read More
Stereotactic radiation effective option for kidney cancer patients
Kidney cancer patients may soon have an alternative to traditional treatments, new research in the USA at UT Southwestern Medical Center‘s Kidney... Read More
Doctors in US perform the first robotic surgery to remove kidney cancer extending into the heart
A surgical team at Keck Medicine of USC pushed the boundaries of clinical care by performing the first-ever robotic, minimally invasive surgical... Read More
Petition: The Future of the Cancer Drugs Fund and NICE reform
As part of the ‘Access to Cancer Medicines Charity Coalition’, Kidney Cancer UK urgently need your help to stop plans that would... Read More
